Melaloque®
Melaloque® is a topical depigmentation formulation developed to assist healthcare professionals in the management of hyperpigmentation disorders associated with increased melanin production and inflammatory skin responses. The formulation combines depigmenting, keratoregulating, and anti-inflammatory components to support structured dermatological care.
It is formulated for short-term, physician-directed management of pigmentary skin conditions.
Dosage Form
Cream
Therapeutic Category
Depigmenting Combination
Pack Size
15 g
Route of Administration
Topical
Formulated For
Dermatologist-directed pigmentation management
Brand
Indigammy
Melaloque® combines three dermatologically active components with complementary roles:
- Hydroquinone assists in reducing melanin synthesis by inhibiting tyrosinase activity involved in pigmentation pathways.
- Tretinoin supports epidermal cell turnover and assists in dispersion of existing pigment deposits.
- Mometasone Furoate helps regulate inflammatory responses that may contribute to post-inflammatory pigmentation.
The formulation assists in managing uneven pigmentation while helping maintain skin tolerability when used under dermatological supervision. Due to the presence of corticosteroid and depigmenting agents, treatment duration should be carefully monitored by healthcare professionals.